Esomeprazole Magnesium
- Product NDC
- 13668-550
- 11-digit product format
- 136680550
- Labeler code
- 13668
- Product ID
- 13668-550_3e6da063-fd01-4d9f-8b56-5e7cf3e15223
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Esomeprazole Magnesium
- Dosage form
- GRANULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Torrent Pharmaceuticals Limited
- Application
- ANDA212651
- Marketing category
- ANDA
- Marketing start
- 2025-03-05
- Substance
- ESOMEPRAZOLE MAGNESIUM
- Active strength
- 40 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212651-001 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | |
| A212651-002 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | |
| A212651-003 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | |
| A212651-004 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212651-001 | AB |
| A212651-002 | AB |
| A212651-003 | AB |
| A212651-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | fd3edfee7708… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-001 | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-002 | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-003 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-004 | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | AB | 2025-03-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A212651-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A212651-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A212651-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A212651-004 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A212651-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A212651-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A212651-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A212651-004 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A212651-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212651-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212651-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212651-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212651-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212651-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212651-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212651-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212651-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212651-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212651-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212651-004 | AB | 1 | fd3edfee7708… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212651-004 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Esomeprazole Magnesium
- Brand name suffix
- for delayed-release oral suspension
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESOMEPRAZOLE MAGNESIUM | 40 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R6DXU4WAY9 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 992b1830-55cc-4e95-8d6d-e7f796d5b373 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7006a36-e68d-42e2-8cd3-d725cb2e47b1 | Product name | 6 | 20251027 |
| cb89b86a-369e-4204-8910-ae797c503af3 | Product name | 1 | 20230706 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| d4880ace-a516-8c47-8dfd-73a4ba5887d7 | Product name | 2 | 20180830 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d71865e8-5c35-4d76-8ecd-a7adda982240 | Product name | 9 | 20180628 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d71865e8-5c35-4d76-8ecd-a7adda982240 | Product name | 8 | 20171212 |
| 094c6751-235c-4d12-acee-2baf94f676f4 | Product name | 1 | 20151116 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13668-550-94 | Esomeprazole Magnesiumfor delayed-release oral suspension | 30 in 1 CARTON | GRANULE, DELAYED RELEASE | 30 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13668-550-94 | EA - Each | 13668-550 | 1f0edf14-305c-4a2a-919a-1b50d6eedb8b | 1 | 2025-05-14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 13668-550 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 5 | Current NDC, 1 package rows | 20250313_992b1830-55cc-4e95-8d6d-e7f796d5b373.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Esomeprazole Magnesium for delayed-release oral suspension | ESOMEPRAZOLE MAGNESIUM | Torrent Pharmaceuticals Limited | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 2026-05-06 | Warnings, Adverse reactions | 212651 ANDA212651 13668-550 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1297658 | esomeprazole 2.5 MG Granules for Delayed Release Oral Suspension | PSN | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692576 | esomeprazole 20 MG Granules for Delayed Release Oral Suspension | PSN | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692578 | esomeprazole 40 MG Granules for Delayed Release Oral Suspension | PSN | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 1297761 | esomeprazole 5 MG Granules for Delayed Release Oral Suspension | PSN | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 1297658 | esomeprazole 2.5 MG Granules for Oral Suspension | SCD | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692576 | esomeprazole 20 MG Granules for Oral Suspension | SCD | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692578 | esomeprazole 40 MG Granules for Oral Suspension | SCD | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 1297761 | esomeprazole 5 MG Granules for Oral Suspension | SCD | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 1297658 | esomeprazole (as esomeprazole magnesium) 2.5 MG Granules for Delayed Release Oral Suspension | SY | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692576 | esomeprazole (as esomeprazole magnesium) 20 MG Granules for Delayed Release Oral Suspension | SY | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692576 | esomeprazole 20 MG Granules for Delayed Release Oral Suspension | SY | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692578 | esomeprazole 40 MG (equivalent to esomeprazole magnesium 44.5 MG) Granules for Delayed Release Oral Suspension | SY | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 692578 | esomeprazole 40 MG Granules for Delayed Release Oral Suspension | SY | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
| 1297761 | esomeprazole 5 MG (equivalent to esomeprazole magnesium 5.6 MG) Granules for Delayed Release Oral Suspension | SY | 992b1830-55cc-4e95-8d6d-e7f796d5b373 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 13668-550-94 | 13668055094 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (13668-550-94) | 2025-03-05 | No | No | Current |